The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.

Wilkerson, Jenny L

The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model. [electronic resource] - The Journal of pharmacology and experimental therapeutics Apr 2016 - 145-56 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1521-0103

10.1124/jpet.115.229971 doi


Analgesics, Opioid--therapeutic use
Animals
Arachidonic Acids--metabolism
Behavior, Animal--drug effects
Carbamates--pharmacology
Constriction, Pathologic--complications
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Synergism
Endocannabinoids--metabolism
Enzyme Inhibitors--pharmacology
Glycerides--metabolism
Hyperalgesia--chemically induced
Male
Mice
Mice, Inbred C57BL
Monoacylglycerol Lipases--antagonists & inhibitors
Morphine--administration & dosage
Neuralgia--chemically induced
Receptor, Cannabinoid, CB1--drug effects
Receptor, Cannabinoid, CB2--drug effects
Receptors, Opioid, mu--drug effects
Succinimides--pharmacology